iVexSol, Inc. is a viral vector manufacturing company founded on a proprietary, next-generation, stable lentiviral vector production process that transforms the way these essential gene-delivery vehicles are made. Our Intelligent Manufacturing™ platform ensures the robust and reliable production of high quality, high-titer vector by generating a clonally derived Master Cell Bank of stable vector-producing cells for the production of your gene of interest. Expansion, harvest and release of a vial from your bank enables us to deliver ready-to-use vector “on demand (i.e., within weeks, not months of your order), preserving and accelerating your clinical development timeline.